Monsanto (MON) Receives “Buy” Rating from Deutsche Bank
MON has been the topic of a number of other research reports. Royal Bank of Canada restated a hold rating and issued a $128.00 price target on shares of Monsanto in a research report on Wednesday, November 15th. Macquarie downgraded shares of Monsanto from an outperform rating to a neutral rating in a research report on Wednesday, October 4th. BMO Capital Markets reiterated a buy rating and set a $128.00 target price on shares of Monsanto in a research report on Thursday, October 5th. Barclays reiterated an equal weight rating and set a $124.00 target price (up previously from $120.00) on shares of Monsanto in a research report on Thursday, October 5th. Finally, Zacks Investment Research downgraded shares of Monsanto from a buy rating to a hold rating in a research report on Monday, December 11th. Eleven research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. The stock has an average rating of Hold and a consensus target price of $127.30.
Shares of Monsanto (NYSE MON) traded up $1.80 during midday trading on Tuesday, hitting $120.66. 6,986,210 shares of the stock were exchanged, compared to its average volume of 3,940,800. The firm has a market cap of $53,110.00, a P/E ratio of 22.30, a P/E/G ratio of 1.70 and a beta of 1.04. Monsanto has a 1 year low of $106.97 and a 1 year high of $122.79. The company has a quick ratio of 0.79, a current ratio of 1.28 and a debt-to-equity ratio of 1.05.
Monsanto (NYSE:MON) last issued its quarterly earnings results on Thursday, January 4th. The basic materials company reported $0.41 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.42 by ($0.01). The firm had revenue of $2.66 billion during the quarter, compared to analyst estimates of $2.77 billion. Monsanto had a return on equity of 40.13% and a net margin of 16.38%. The firm’s revenue for the quarter was up .3% on a year-over-year basis. During the same quarter last year, the firm posted $0.21 EPS. sell-side analysts expect that Monsanto will post 5.76 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Friday, January 5th will be issued a dividend of $0.54 per share. The ex-dividend date of this dividend is Thursday, January 4th. This represents a $2.16 annualized dividend and a yield of 1.79%. Monsanto’s payout ratio is 39.93%.
In other Monsanto news, EVP Steven Mizell sold 8,100 shares of the company’s stock in a transaction on Tuesday, January 9th. The shares were sold at an average price of $119.35, for a total transaction of $966,735.00. Following the transaction, the executive vice president now owns 56,743 shares in the company, valued at $6,772,277.05. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 0.79% of the company’s stock.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Personal Capital Advisors Corp raised its holdings in Monsanto by 9.8% during the fourth quarter. Personal Capital Advisors Corp now owns 202,371 shares of the basic materials company’s stock worth $23,633,000 after buying an additional 18,004 shares during the last quarter. State of Alaska Department of Revenue raised its holdings in Monsanto by 41.7% during the fourth quarter. State of Alaska Department of Revenue now owns 161,990 shares of the basic materials company’s stock worth $18,915,000 after buying an additional 47,698 shares during the last quarter. Havens Advisors LLC raised its holdings in Monsanto by 14.0% during the fourth quarter. Havens Advisors LLC now owns 98,000 shares of the basic materials company’s stock worth $11,444,000 after buying an additional 12,000 shares during the last quarter. Schwab Charles Investment Management Inc. raised its holdings in Monsanto by 3.5% during the fourth quarter. Schwab Charles Investment Management Inc. now owns 1,628,413 shares of the basic materials company’s stock worth $190,167,000 after buying an additional 54,336 shares during the last quarter. Finally, Creative Planning raised its holdings in Monsanto by 4.2% during the fourth quarter. Creative Planning now owns 26,559 shares of the basic materials company’s stock worth $3,102,000 after buying an additional 1,061 shares during the last quarter. Hedge funds and other institutional investors own 75.37% of the company’s stock.
TRADEMARK VIOLATION WARNING: “Monsanto (MON) Receives “Buy” Rating from Deutsche Bank” was reported by Daily Political and is the property of of Daily Political. If you are accessing this story on another domain, it was illegally stolen and republished in violation of U.S. and international trademark and copyright laws. The legal version of this story can be read at https://www.dailypolitical.com/2018/01/19/monsanto-mon-receives-buy-rating-from-deutsche-bank.html.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.